What is PatSnap?

Your R&D might be worth more than you think, thanks to innovation incentives

Most businesses underestimate what they can claim from innovation incentives. According to the Telegraph, 40% of active companies in the UK generate some form of innovation, yet most business owners have no idea that they qualify for R&D tax credits.

Read More

Enhance your innovation cycle by knowing customers, competitors and collaborators

Research by CEB reveals that the top priority of R&D leaders is to beat competitors to market with big innovations—but 90% of them also believe their pipelines are slow at turning ideas into successful products. According to the same research, R&D managers report that one third of their projects are behind schedule. Enhancing the innovation cycle is not just about speed to market, it’s also about ensuring your product is profitable so that R&D resources aren’t wasted.

Read More

UK Government explains how it’s tackling IP crime in latest report

During 2016, over 2 million suspected infringing counterfeit goods were detained by border force. IP crime not only impacts the UK economy but also undermines legitimate businesses who work hard to innovate.

Read More

PatSnap Insights: Pfizer's Viagra Patent Expires

Viagra, or Sildenafil Citrate, is currently patented by Pfizer in the United States, and the patent is set to expire there in April 2020. The company has already signed an agreement to allow Teva Pharmaceuticals to bring a generic Viagra drug to the US market by the end of 2017, and for such an important drug, the implications for both Pfizer and the wider market are expected to be significant. The original patent can be found here in the PatSnap database: US6469012.

Read More

Struggling to build a culture of innovation? Maybe it’s you, not them

Last week, I had the pleasure of interviewing Mitch Ditkoff, an innovation culture consultant who has worked with GE`s Crotonville Management Development Center, Fuqua School of Business and several Fortune 500 companies.

Read More

Interplay between patent law and reproducibility

A patent is a legally granted right to manufacture, use, or sell an invention for a certain number of years, and to exclude others from doing so. Patents are granted in exchange for the detailed, public disclosure of the invention they describe.

Read More

Identifying similar patents in your technology space [Webinar]

This webinar was hosted by PatSnap’s head of product support, Jarrod Britton, and he considered different ways of identifying similar patents in your technology space.

Read More

Webinar: Reducing patent annuity costs

In this webinar, we were joined by our guest speaker Peter Rouse, director at Patent Annuity Costs Ltd.

Read More

Which countries allow software patents?

Patentability of software is a tricky subject as the variations from country to country are less than clear. A common misconception is that it’s easier to patent in the US than in Europe – this is simply not the case; a major contradiction being the landmark Alice. Following the decision in Alice, most patent applications for software have been declared invalid due to unpatentability. There have also been significant developments further afield.

Read More

15 top industry spanning innovations

Coming up with a new idea is a challenge in any walk of life; innovation, especially useful and profitable innovation, is no mean feat. While necessity is indeed the mother of invention, only considering the necessities of your own industry could get in the way of seeing the opportunities lying elsewhere. Cross industry innovation is the application of one industry’s novelties to another.

Read More